IMHOTEX LIMITED

Active Cambridge

Research and experimental development on biotechnology

0 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
I

IMHOTEX LIMITED

Research and experimental development on biotechnology

Founded 5 Feb 2020 Active Cambridge, England 0 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 2 Dec 2025 Next due 30 Nov 2026 5 months remaining
Confirmation Submitted 4 Feb 2026 Next due 18 Feb 2027 8 months remaining
Net assets £822K £2M 2024 year on year
Total assets £935K £2M 2024 year on year
Total Liabilities £113K £54K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

The Cambridge Partnership Dorothy Hodgkin Building Babraham Cambridge CB22 3FH England

Website

www.example.com

Full company profile for IMHOTEX LIMITED (12443280), an active life sciences and medical technology company based in Cambridge, England. Incorporated 5 Feb 2020. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Mar → 28 Feb 2025
Type total-exemption-full
Next accounts 28 Feb 2026
Due by 30 Nov 2026 5 months remaining

Net Assets, Total Assets & Total Liabilities (2020–2024)

Cash in Bank

£659.38k

Decreased by £868.65k (-57%)

Net Assets

£822.27k

Decreased by £1.66M (-67%)

Total Liabilities

£113.05k

Decreased by £53.85k (-32%)

Turnover

N/A

Employees

N/A

Decreased by 1 (-100%)

Debt Ratio

12%

Increased by 6 (+100%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
28 Feb Year End
2024
29 Feb Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

4 Allotments 1,962,879 Shares £1.37m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
28 Apr 2020306,716£30.672£0
28 Apr 2020224,922£22.492£0
18 Feb 20201,369,999£1.37m£1
18 Feb 202061,242£6.124£0

Officers

Officers

2 active 1 resigned
Status
David John GraingerDirectorBritishEngland595 Feb 2020Active
Francesco De RubertisDirectorItalianSwitzerland5614 Feb 2020Active

Shareholders

Shareholders (6)

Medicxi Iii Lp
69.3%
Anthony Segal
18.9%

Persons with Significant Control

Persons with Significant Control (0)

0 Active 2 Ceased

David John Grainger

Ceased 2 Mar 2020

Ceased

Medicxi Iii Lp

Ceased 2 Mar 2020

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
4 Feb 2026Confirmation StatementConfirmation statement made on 4 Feb 2026 with no updates
2 Dec 2025AccountsAnnual accounts made up to 28 Feb 2025
7 Feb 2025Confirmation StatementConfirmation statement made on 4 Feb 2025 with no updates
14 Jan 2025IncorporationMemorandum Articles
13 Jan 2025ResolutionResolutions
4 Feb 2026 Confirmation Statement

Confirmation statement made on 4 Feb 2026 with no updates

2 Dec 2025 Accounts

Annual accounts made up to 28 Feb 2025

7 Feb 2025 Confirmation Statement

Confirmation statement made on 4 Feb 2025 with no updates

14 Jan 2025 Incorporation

Memorandum Articles

13 Jan 2025 Resolution

Resolutions

Recent Activity

Latest Activity

Confirmation statement made on 4 Feb 2026 with no updates

4 months ago on 4 Feb 2026

Annual accounts made up to 28 Feb 2025

6 months ago on 2 Dec 2025

Confirmation statement made on 4 Feb 2025 with no updates

1 years ago on 7 Feb 2025

Memorandum Articles

1 years ago on 14 Jan 2025

Resolutions

1 years ago on 13 Jan 2025